European journal of obstetrics, gynecology, and reproductive biology · 2026
Arabin pessary for preterm birth prevention in women with a short cervix: A long-term comparative study of those with and without prior preterm birth at a single tertiary center in Italy.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oumaima Ammar, Camilla Lippi, Laura Fornasier, Giulia Cutajar, Francesca Bertoli, Viola Seravalli, Mariarosaria Di Tommaso
Аннотация
OBJECTIVE: To compare pregnancy outcomes among women with a short cervix treated with an Arabin pessary according to the presence or absence of a history of spontaneous preterm birth (sPTB) or second-trimester pregnancy loss.
PATIENTS AND METHODS: This single-center, retrospective study included 145 women at risk for sPTB due to a cervical length (CL) < 25 mm before 24 weeks, undergoing Arabin pessary insertion between 16 + 0 and 24 + 6 weeks. Women were stratified into two groups: those with prior sPTB or second-trimester pregnancy loss (n = 32) and those without (n = 113). All women received concomitant vaginal progesterone according to local protocol.
RESULTS: There were no significant differences in gestational age at delivery (37.9 vs 38.5 weeks, p = 0.154) or sPTB rates before 34 weeks (23.3% vs 19.6%, p = 0.415) between groups. However, the group with prior sPTB had a higher pregnancy loss rate below 22 weeks (9.4% vs 0.9%, p = 0.034). In women without prior sPTB, CL correlated with latency to delivery (r = 0.330, p = 0.005), and CL and gestational age at pessary insertion were independent predictors of sPTB < 34 weeks.
CONCLUSION: Among women with a short cervix managed with Arabin pessary plus vaginal progesterone, overall pregnancy outcomes were similar regardless of prior sPTB history. The higher rate of pregnancy loss < 22 weeks in women with prior second-trimester pregnancy loss suggests the need for further evaluation and individualized management in this subgroup.
PATIENTS AND METHODS: This single-center, retrospective study included 145 women at risk for sPTB due to a cervical length (CL) < 25 mm before 24 weeks, undergoing Arabin pessary insertion between 16 + 0 and 24 + 6 weeks. Women were stratified into two groups: those with prior sPTB or second-trimester pregnancy loss (n = 32) and those without (n = 113). All women received concomitant vaginal progesterone according to local protocol.
RESULTS: There were no significant differences in gestational age at delivery (37.9 vs 38.5 weeks, p = 0.154) or sPTB rates before 34 weeks (23.3% vs 19.6%, p = 0.415) between groups. However, the group with prior sPTB had a higher pregnancy loss rate below 22 weeks (9.4% vs 0.9%, p = 0.034). In women without prior sPTB, CL correlated with latency to delivery (r = 0.330, p = 0.005), and CL and gestational age at pessary insertion were independent predictors of sPTB < 34 weeks.
CONCLUSION: Among women with a short cervix managed with Arabin pessary plus vaginal progesterone, overall pregnancy outcomes were similar regardless of prior sPTB history. The higher rate of pregnancy loss < 22 weeks in women with prior second-trimester pregnancy loss suggests the need for further evaluation and individualized management in this subgroup.